Review




Structured Review

Novartis daptomycin dap
Daptomycin Dap, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/daptomycin/daptomycin/pm42041290-232-0-8
Average 86 stars, based on 1 article reviews
daptomycin dap - by Bioz Stars, 2026-11
86/100 stars

Images

Related Articles

other:

Article Title: Epidemiology of Staphylococcus aureus in Italy: First nationwide survey, 2012.
Article Snippet: Accepted Manuscript Title: Epidemiology of Staphylococcus aureus in Italy: first nationwide survey, 2012 Author: Floriana Campanile Dafne Bongiorno Marianna Perez Gino Mongelli Laura Sessa Sabrina Benvenuto Floriana Gona Pietro E. Varaldo Stefania StefaniThe AMCLI–S. aureus Survey Participants are listed in the Appendix. PII: S2213-7165(15)00068-5 DOI: http://dx.doi.org/doi:10.1016/j.jgar.2015.06.006 Reference: JGAR 169 To appear in: Received date: 28-1-2015 Revised date: 9-6-2015 Accepted date: 24-6-2015 Please cite this article as: Campanile F, Bongiorno D, Perez M, Mongelli G, Sessa L, Benvenuto S, Gona F, Varaldo PE, Stefani S, Epidemiology of Staphylococcus aureus in Italy: first nationwide survey, 2012, Journal of Global Antimicrobial Resistance (2010), http://dx.doi.org/10.1016/j.jgar.2015.06.006 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript.. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form.

Article Title: Tetrabromobisphenol A (TBBPA) inhibits Bacillus subtilis as a Membrane Active Antibacterial Agent
Article Snippet: Daptomycin was purchased from Novartis.

Article Title: Antimicrobial Activity of Ceragenins against Vancomycin-Susceptible and -Resistant Enterococcus spp.
Article Snippet: Antibiotics were kindly provided by their manufacturers such as linezolid and vancomycin from Koçak Farma İlaç ve Kimya Sanayi A.Ş., and daptomycin from Novartis Sağlık, Gıda, Tarım Ürünleri San.

Article Title: Antimicrobial Activity of Ceragenins against Vancomycin-Susceptible and -Resistant Enterococcus spp.
Article Snippet: Antibiotics were kindly provided by their manufacturers such as linezolid and vancomycin from Koçak Farma İlaç ve Kimya Sanayi A.Ş., and daptomycin from Novartis Sağlık, Gıda, Tarım Ürünleri San.

Article Title: Medicament and use thereof for treating bacterial infections involving biofilm
Article Snippet: Daptomycin is a naturally occurring lipo-peptide of the following structure: Daptomycin is marketed in the EU by Novartis and in the US by Cubist Pharmaceuticals.

Article Title: Evaluation of ampicillin plus ceftobiprole combination therapy in treating Enterococcus faecalis infective endocarditis and bloodstream infection.
Article Snippet: Ceftobiprole was provided by Basilea Pharmaceutica International Ltd. (Basel, Switzerland); ceftaroline, linezolid and tigecycline by Pfizer Inc. (New York, NY, USA); daptomycin by Novartis (Basel, Switzerland).

Clinical Proteomics:

Article Title:
Article Snippet: .. Novartis plans to start clinical trials with other antibacterials, such as daptomycin, as an add-on therapy. ..



Similar Products

94
MedChemExpress daptomycin
Tolerance of S. aureus to membrane perturbation by Triton X-100 in low Mg 2+ and Ca 2+ or <t>daptomycin</t> treatment requires efficient alanine uptake or 2 mM Mg 2+ /Ca 2+ . ( A ) Lysis in the presence of 0.05% Triton X-100 of the wild-type JE2, the alanine transporter mutant ( aapA ::tn), or the complemented aapA mutant ( aapA ::tn pRMC2:: aapA ) in defined medium containing 0 alanine and low (0.04 mM each) Mg 2+ and Ca 2+ or with the addition of 1 mM L-alanine in low Mg 2+ and Ca 2+ , or 1 mM L-alanine and 2 mM Mg 2+ and Ca 2+ . ( B ) Growth of wild-type JE2 or alanine transporter mutant aapA ::tn in defined medium containing 2 mM Ca 2+ and 0.1 or 1 mM L-alanine with or without 1 µM Daptomycin. Data are displayed as the mean +/− SEM of 3 biological replicates containing 3 technical replicates per experiment.
Daptomycin, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/daptomycin/Daptomycin/pmc13304347-66-2-3
Average 94 stars, based on 1 article reviews
daptomycin - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Thermo Fisher daptomycin
Tolerance of S. aureus to membrane perturbation by Triton X-100 in low Mg 2+ and Ca 2+ or <t>daptomycin</t> treatment requires efficient alanine uptake or 2 mM Mg 2+ /Ca 2+ . ( A ) Lysis in the presence of 0.05% Triton X-100 of the wild-type JE2, the alanine transporter mutant ( aapA ::tn), or the complemented aapA mutant ( aapA ::tn pRMC2:: aapA ) in defined medium containing 0 alanine and low (0.04 mM each) Mg 2+ and Ca 2+ or with the addition of 1 mM L-alanine in low Mg 2+ and Ca 2+ , or 1 mM L-alanine and 2 mM Mg 2+ and Ca 2+ . ( B ) Growth of wild-type JE2 or alanine transporter mutant aapA ::tn in defined medium containing 2 mM Ca 2+ and 0.1 or 1 mM L-alanine with or without 1 µM Daptomycin. Data are displayed as the mean +/− SEM of 3 biological replicates containing 3 technical replicates per experiment.
Daptomycin, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/daptomycin/Daptomycin/pmc12771081-49-1-2
Average 94 stars, based on 1 article reviews
daptomycin - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

86
Tokyo Chemical Industry daptomycin
Tolerance of S. aureus to membrane perturbation by Triton X-100 in low Mg 2+ and Ca 2+ or <t>daptomycin</t> treatment requires efficient alanine uptake or 2 mM Mg 2+ /Ca 2+ . ( A ) Lysis in the presence of 0.05% Triton X-100 of the wild-type JE2, the alanine transporter mutant ( aapA ::tn), or the complemented aapA mutant ( aapA ::tn pRMC2:: aapA ) in defined medium containing 0 alanine and low (0.04 mM each) Mg 2+ and Ca 2+ or with the addition of 1 mM L-alanine in low Mg 2+ and Ca 2+ , or 1 mM L-alanine and 2 mM Mg 2+ and Ca 2+ . ( B ) Growth of wild-type JE2 or alanine transporter mutant aapA ::tn in defined medium containing 2 mM Ca 2+ and 0.1 or 1 mM L-alanine with or without 1 µM Daptomycin. Data are displayed as the mean +/− SEM of 3 biological replicates containing 3 technical replicates per experiment.
Daptomycin, supplied by Tokyo Chemical Industry, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/daptomycin/daptomycin/pm42321333-75-0-4
Average 86 stars, based on 1 article reviews
daptomycin - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Eli Lilly daptomycin
Tolerance of S. aureus to membrane perturbation by Triton X-100 in low Mg 2+ and Ca 2+ or <t>daptomycin</t> treatment requires efficient alanine uptake or 2 mM Mg 2+ /Ca 2+ . ( A ) Lysis in the presence of 0.05% Triton X-100 of the wild-type JE2, the alanine transporter mutant ( aapA ::tn), or the complemented aapA mutant ( aapA ::tn pRMC2:: aapA ) in defined medium containing 0 alanine and low (0.04 mM each) Mg 2+ and Ca 2+ or with the addition of 1 mM L-alanine in low Mg 2+ and Ca 2+ , or 1 mM L-alanine and 2 mM Mg 2+ and Ca 2+ . ( B ) Growth of wild-type JE2 or alanine transporter mutant aapA ::tn in defined medium containing 2 mM Ca 2+ and 0.1 or 1 mM L-alanine with or without 1 µM Daptomycin. Data are displayed as the mean +/− SEM of 3 biological replicates containing 3 technical replicates per experiment.
Daptomycin, supplied by Eli Lilly, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/daptomycin/daptomycin/pm42303174-27-2-6
Average 86 stars, based on 1 article reviews
daptomycin - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

94
Thermo Fisher bodipy 493 503
( A ) Binding of <t>BODIPY-labeled</t> daptomycin (BODIPY-Dap) in the previously determined subinhibitory concentration of 7.81 µg/mL to the S. capitis NRCS-A isolate ScSK1 (light blue) and the non-invasive S. capitis DSM6717 (dark blue). Bacterial cells were incubated with BODIPY-Dap and analyzed by flow cytometry (FITC channel) at 0 h, 0.5 h, 1 h, and 2 h. Statistical analysis was performed using two-way ANOVA with Šidák’s multiple-comparisons test to compare BODIPY-Dap binding between strains at each time point ( P < 0.05, * P < 0.01, ** P < 0.001). Data are shown as mean ± SD from at least four independent experiments. ( B ) Fluorescence microscopy of S. capitis strains DSM6717 and ScSK1 after incubation with BODIPY-Dap for 0, 10, 30, and 60 min. Representative images were acquired on a Zeiss LSM 800 confocal microscope using a 100× objective. Scale bar, 2 µm.
Bodipy 493 503, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/daptomycin/Daptomycin/pmc13148029-69-0-3
Average 94 stars, based on 1 article reviews
bodipy 493 503 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

86
Liofilchem daptomycin
<t>Daptomycin</t> and vancomycin susceptibility of S. capitis NRCS-A isolates (ScSK) from our local collection as determined by MIC test strip. MICs of ( A ) daptomycin and ( B ) vancomycin are shown. Black lines indicate cut-off concentrations for resistance: 1 μg/mL for daptomycin, 2 μg/mL for vancomycin reduced susceptibility (cut-off for S. aureus ), and 4 μg/mL for vancomycin resistance (EUCAST definition, v15.0 of 2025). The S. aureus SA113 WT and SA113 ∆ mprF (gray), which is more susceptible to daptomycin and vancomycin, were used as controls. NRCS-A isolates (light blue) were compared with non-invasive S. capitis strain DSM6717 (dark blue) and the S. capitis bloodstream isolate from a toddler’s catheter sepsis (ScSK11, turquoise). The mean ± SEM of at least three independent experiments is shown.
Daptomycin, supplied by Liofilchem, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/daptomycin/daptomycin/pmc13148029-61-5-8
Average 86 stars, based on 1 article reviews
daptomycin - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Apollo Scientific Ltd daptomycin lipopeptide
<t>Daptomycin</t> and vancomycin susceptibility of S. capitis NRCS-A isolates (ScSK) from our local collection as determined by MIC test strip. MICs of ( A ) daptomycin and ( B ) vancomycin are shown. Black lines indicate cut-off concentrations for resistance: 1 μg/mL for daptomycin, 2 μg/mL for vancomycin reduced susceptibility (cut-off for S. aureus ), and 4 μg/mL for vancomycin resistance (EUCAST definition, v15.0 of 2025). The S. aureus SA113 WT and SA113 ∆ mprF (gray), which is more susceptible to daptomycin and vancomycin, were used as controls. NRCS-A isolates (light blue) were compared with non-invasive S. capitis strain DSM6717 (dark blue) and the S. capitis bloodstream isolate from a toddler’s catheter sepsis (ScSK11, turquoise). The mean ± SEM of at least three independent experiments is shown.
Daptomycin Lipopeptide, supplied by Apollo Scientific Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/daptomycin/daptomycin+lipopeptide/pm42107309-82-2-24
Average 86 stars, based on 1 article reviews
daptomycin lipopeptide - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Novartis daptomycin dap
<t>Daptomycin</t> and vancomycin susceptibility of S. capitis NRCS-A isolates (ScSK) from our local collection as determined by MIC test strip. MICs of ( A ) daptomycin and ( B ) vancomycin are shown. Black lines indicate cut-off concentrations for resistance: 1 μg/mL for daptomycin, 2 μg/mL for vancomycin reduced susceptibility (cut-off for S. aureus ), and 4 μg/mL for vancomycin resistance (EUCAST definition, v15.0 of 2025). The S. aureus SA113 WT and SA113 ∆ mprF (gray), which is more susceptible to daptomycin and vancomycin, were used as controls. NRCS-A isolates (light blue) were compared with non-invasive S. capitis strain DSM6717 (dark blue) and the S. capitis bloodstream isolate from a toddler’s catheter sepsis (ScSK11, turquoise). The mean ± SEM of at least three independent experiments is shown.
Daptomycin Dap, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/daptomycin/daptomycin/pm42041290-232-0-8
Average 86 stars, based on 1 article reviews
daptomycin dap - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


Tolerance of S. aureus to membrane perturbation by Triton X-100 in low Mg 2+ and Ca 2+ or daptomycin treatment requires efficient alanine uptake or 2 mM Mg 2+ /Ca 2+ . ( A ) Lysis in the presence of 0.05% Triton X-100 of the wild-type JE2, the alanine transporter mutant ( aapA ::tn), or the complemented aapA mutant ( aapA ::tn pRMC2:: aapA ) in defined medium containing 0 alanine and low (0.04 mM each) Mg 2+ and Ca 2+ or with the addition of 1 mM L-alanine in low Mg 2+ and Ca 2+ , or 1 mM L-alanine and 2 mM Mg 2+ and Ca 2+ . ( B ) Growth of wild-type JE2 or alanine transporter mutant aapA ::tn in defined medium containing 2 mM Ca 2+ and 0.1 or 1 mM L-alanine with or without 1 µM Daptomycin. Data are displayed as the mean +/− SEM of 3 biological replicates containing 3 technical replicates per experiment.

Journal: Microorganisms

Article Title: Alanine Uptake Is Required to Maintain Staphylococcus aureus Cell Envelope Stability Under Magnesium and Calcium Limitation

doi: 10.3390/microorganisms14061332

Figure Lengend Snippet: Tolerance of S. aureus to membrane perturbation by Triton X-100 in low Mg 2+ and Ca 2+ or daptomycin treatment requires efficient alanine uptake or 2 mM Mg 2+ /Ca 2+ . ( A ) Lysis in the presence of 0.05% Triton X-100 of the wild-type JE2, the alanine transporter mutant ( aapA ::tn), or the complemented aapA mutant ( aapA ::tn pRMC2:: aapA ) in defined medium containing 0 alanine and low (0.04 mM each) Mg 2+ and Ca 2+ or with the addition of 1 mM L-alanine in low Mg 2+ and Ca 2+ , or 1 mM L-alanine and 2 mM Mg 2+ and Ca 2+ . ( B ) Growth of wild-type JE2 or alanine transporter mutant aapA ::tn in defined medium containing 2 mM Ca 2+ and 0.1 or 1 mM L-alanine with or without 1 µM Daptomycin. Data are displayed as the mean +/− SEM of 3 biological replicates containing 3 technical replicates per experiment.

Article Snippet: Susceptibility to daptomycin (MedChemExpress, Monmouth Junction, NJ, USA) was tested according to our standard growth assay described above.

Techniques: Membrane, Lysis, Mutagenesis

( A ) Binding of BODIPY-labeled daptomycin (BODIPY-Dap) in the previously determined subinhibitory concentration of 7.81 µg/mL to the S. capitis NRCS-A isolate ScSK1 (light blue) and the non-invasive S. capitis DSM6717 (dark blue). Bacterial cells were incubated with BODIPY-Dap and analyzed by flow cytometry (FITC channel) at 0 h, 0.5 h, 1 h, and 2 h. Statistical analysis was performed using two-way ANOVA with Šidák’s multiple-comparisons test to compare BODIPY-Dap binding between strains at each time point ( P < 0.05, * P < 0.01, ** P < 0.001). Data are shown as mean ± SD from at least four independent experiments. ( B ) Fluorescence microscopy of S. capitis strains DSM6717 and ScSK1 after incubation with BODIPY-Dap for 0, 10, 30, and 60 min. Representative images were acquired on a Zeiss LSM 800 confocal microscope using a 100× objective. Scale bar, 2 µm.

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Polygenic, cell-envelope adaptations drive high-frequency daptomycin resistance in Staphylococcus capitis NRCS-A from neonatal sepsis and NEC

doi: 10.1128/aac.01414-25

Figure Lengend Snippet: ( A ) Binding of BODIPY-labeled daptomycin (BODIPY-Dap) in the previously determined subinhibitory concentration of 7.81 µg/mL to the S. capitis NRCS-A isolate ScSK1 (light blue) and the non-invasive S. capitis DSM6717 (dark blue). Bacterial cells were incubated with BODIPY-Dap and analyzed by flow cytometry (FITC channel) at 0 h, 0.5 h, 1 h, and 2 h. Statistical analysis was performed using two-way ANOVA with Šidák’s multiple-comparisons test to compare BODIPY-Dap binding between strains at each time point ( P < 0.05, * P < 0.01, ** P < 0.001). Data are shown as mean ± SD from at least four independent experiments. ( B ) Fluorescence microscopy of S. capitis strains DSM6717 and ScSK1 after incubation with BODIPY-Dap for 0, 10, 30, and 60 min. Representative images were acquired on a Zeiss LSM 800 confocal microscope using a 100× objective. Scale bar, 2 µm.

Article Snippet: BODIPY 493/503 (4,4-Difluoro-1,3,5,7,8-Pentamethyl-4-Bora-3a,4a-Diaza-s-Indacen) (Invitrogen/Thermo-Fisher, D3922) labeling of daptomycin was performed as described previously ( , ).

Techniques: Binding Assay, Labeling, Concentration Assay, Incubation, Flow Cytometry, Fluorescence, Microscopy

Daptomycin and vancomycin susceptibility of S. capitis NRCS-A isolates (ScSK) from our local collection as determined by MIC test strip. MICs of ( A ) daptomycin and ( B ) vancomycin are shown. Black lines indicate cut-off concentrations for resistance: 1 μg/mL for daptomycin, 2 μg/mL for vancomycin reduced susceptibility (cut-off for S. aureus ), and 4 μg/mL for vancomycin resistance (EUCAST definition, v15.0 of 2025). The S. aureus SA113 WT and SA113 ∆ mprF (gray), which is more susceptible to daptomycin and vancomycin, were used as controls. NRCS-A isolates (light blue) were compared with non-invasive S. capitis strain DSM6717 (dark blue) and the S. capitis bloodstream isolate from a toddler’s catheter sepsis (ScSK11, turquoise). The mean ± SEM of at least three independent experiments is shown.

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Polygenic, cell-envelope adaptations drive high-frequency daptomycin resistance in Staphylococcus capitis NRCS-A from neonatal sepsis and NEC

doi: 10.1128/aac.01414-25

Figure Lengend Snippet: Daptomycin and vancomycin susceptibility of S. capitis NRCS-A isolates (ScSK) from our local collection as determined by MIC test strip. MICs of ( A ) daptomycin and ( B ) vancomycin are shown. Black lines indicate cut-off concentrations for resistance: 1 μg/mL for daptomycin, 2 μg/mL for vancomycin reduced susceptibility (cut-off for S. aureus ), and 4 μg/mL for vancomycin resistance (EUCAST definition, v15.0 of 2025). The S. aureus SA113 WT and SA113 ∆ mprF (gray), which is more susceptible to daptomycin and vancomycin, were used as controls. NRCS-A isolates (light blue) were compared with non-invasive S. capitis strain DSM6717 (dark blue) and the S. capitis bloodstream isolate from a toddler’s catheter sepsis (ScSK11, turquoise). The mean ± SEM of at least three independent experiments is shown.

Article Snippet: Therefore, MIC test strips for daptomycin and vancomycin (Liofilchem) were applied on MHB agar plates and analyzed after 24 h incubation at 37°C according to the manufacturer’s protocol.

Techniques: Stripping Membranes

( A ) Binding of BODIPY-labeled daptomycin (BODIPY-Dap) in the previously determined subinhibitory concentration of 7.81 µg/mL to the S. capitis NRCS-A isolate ScSK1 (light blue) and the non-invasive S. capitis DSM6717 (dark blue). Bacterial cells were incubated with BODIPY-Dap and analyzed by flow cytometry (FITC channel) at 0 h, 0.5 h, 1 h, and 2 h. Statistical analysis was performed using two-way ANOVA with Šidák’s multiple-comparisons test to compare BODIPY-Dap binding between strains at each time point ( P < 0.05, * P < 0.01, ** P < 0.001). Data are shown as mean ± SD from at least four independent experiments. ( B ) Fluorescence microscopy of S. capitis strains DSM6717 and ScSK1 after incubation with BODIPY-Dap for 0, 10, 30, and 60 min. Representative images were acquired on a Zeiss LSM 800 confocal microscope using a 100× objective. Scale bar, 2 µm.

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Polygenic, cell-envelope adaptations drive high-frequency daptomycin resistance in Staphylococcus capitis NRCS-A from neonatal sepsis and NEC

doi: 10.1128/aac.01414-25

Figure Lengend Snippet: ( A ) Binding of BODIPY-labeled daptomycin (BODIPY-Dap) in the previously determined subinhibitory concentration of 7.81 µg/mL to the S. capitis NRCS-A isolate ScSK1 (light blue) and the non-invasive S. capitis DSM6717 (dark blue). Bacterial cells were incubated with BODIPY-Dap and analyzed by flow cytometry (FITC channel) at 0 h, 0.5 h, 1 h, and 2 h. Statistical analysis was performed using two-way ANOVA with Šidák’s multiple-comparisons test to compare BODIPY-Dap binding between strains at each time point ( P < 0.05, * P < 0.01, ** P < 0.001). Data are shown as mean ± SD from at least four independent experiments. ( B ) Fluorescence microscopy of S. capitis strains DSM6717 and ScSK1 after incubation with BODIPY-Dap for 0, 10, 30, and 60 min. Representative images were acquired on a Zeiss LSM 800 confocal microscope using a 100× objective. Scale bar, 2 µm.

Article Snippet: Therefore, MIC test strips for daptomycin and vancomycin (Liofilchem) were applied on MHB agar plates and analyzed after 24 h incubation at 37°C according to the manufacturer’s protocol.

Techniques: Binding Assay, Labeling, Concentration Assay, Incubation, Flow Cytometry, Fluorescence, Microscopy

DAP-R evolution of S. capitis NRCS-A (ScSK4) in light blue compared to non-invasive S. capitis (DSM6717) in dark blue, S. aureus (USA300) in gray, and S. epidermidis (SeSK1) in white. Strains were grown without ( A ) or with ( B ) daptomycin pressure or ( C ) vancomycin pressure in MHB for 24 h followed by daptomycin MIC determination after each passage via E-tests. Black lines indicate cut-off concentrations for daptomycin resistance at 1 μg/mL (EUCAST definition, v15.0 of 2025). The black arrows highlight the passaging days on which bacterial strains evolved a DAP-R phenotype.

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Polygenic, cell-envelope adaptations drive high-frequency daptomycin resistance in Staphylococcus capitis NRCS-A from neonatal sepsis and NEC

doi: 10.1128/aac.01414-25

Figure Lengend Snippet: DAP-R evolution of S. capitis NRCS-A (ScSK4) in light blue compared to non-invasive S. capitis (DSM6717) in dark blue, S. aureus (USA300) in gray, and S. epidermidis (SeSK1) in white. Strains were grown without ( A ) or with ( B ) daptomycin pressure or ( C ) vancomycin pressure in MHB for 24 h followed by daptomycin MIC determination after each passage via E-tests. Black lines indicate cut-off concentrations for daptomycin resistance at 1 μg/mL (EUCAST definition, v15.0 of 2025). The black arrows highlight the passaging days on which bacterial strains evolved a DAP-R phenotype.

Article Snippet: Therefore, MIC test strips for daptomycin and vancomycin (Liofilchem) were applied on MHB agar plates and analyzed after 24 h incubation at 37°C according to the manufacturer’s protocol.

Techniques: Passaging